Researchers are excited about this new drug, a novel dual agonist showing remarkable outcomes in early trials for weight reduction . It acts by modulating several pathways : GLP-1 and GIP, that , when https://philipnriy910104.blogstival.com/62368287/a-new-prospect-for-body-loss